Zhongyong Wang
发表
Hong Lu,
Xiangyang Lin,
Xin Wei,
2020,
Human Immunology.
Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients.
Hong Lu,
Xiangyang Lin,
Xin Wei,
2021,
Immunology letters.
Hong Lu,
Xiangyang Lin,
Xin Wei,
2020,
International Immunopharmacology.
Lijiang Chen,
T. Zhou,
Zhongyong Wang,
2021,
Frontiers in Microbiology.
Jun Cheng,
Changgui Sun,
Zhongyong Wang,
2018,
Medical science monitor : international medical journal of experimental and clinical research.
Hong Lu,
Lianfeng Wu,
Xiangyang Lin,
2020,
Iranian journal of immunology : IJI.
X. Zhang,
Jiayi Wang,
F. Sun,
2015,
Oncotarget.
Yan Jiang,
Kate Huang,
Jia Zhao,
2016
.
Ying Zhang,
Lijiang Chen,
T. Zhou,
2022,
Infection and drug resistance.
Ya-jie Zhao,
Siqin Zhang,
T. Zhou,
2021
.
Ya-jie Zhao,
Siqin Zhang,
T. Zhou,
2020
.
Hong Lu,
Lianfeng Wu,
Xiangyang Lin,
2020,
Clinical Immunology.
Zhongyong Wang,
K. Shi,
Yuehui Chen,
2018,
Journal of Cancer.
D. Cui,
Changjun Wang,
Da-wei Chen,
2016,
American journal of translational research.
Ying Zhang,
T. Zhou,
Zhongyong Wang,
2021,
Infection and drug resistance.
Kate Huang,
Xiangyang Lin,
Zhihua Tao,
2014,
Experimental and molecular pathology.
J. Ji,
Huijuan Tang,
M. Xi,
2020,
Frontiers in Oncology.
Lijiang Chen,
T. Zhou,
Zhongyong Wang,
2022,
Microbial pathogenesis.
T. Zhou,
B. Zheng,
Hao Xu,
2023,
BMC Genomics.
Kate Huang,
Xiangyang Lin,
Zhihua Tao,
2014,
Experimental and molecular pathology.